Higher levels of GATA3 predict better survival in women with breast cancer von Yoon, Nam K., BS, Maresh, Erin L., BS, Shen, Dejun, MD, Elshimali, Yahya, MD, Apple, Sophia, MD, Horvath, Steve, PhD, Mah, Vei, MD, Bose, Shikha, MD, Chia, David, PhD, Chang, Helena R., MD, Goodglick, Lee, PhD

Volltext

Differential response of triple‐negative breast cancer to a docetaxel and carboplatin‐based neoadjuvant treatment von Chang, Helena R., Glaspy, John, Allison, Mary Ann, Kass, Frederic C., Elashoff, Robert, Chung, Debra U., Gornbein, Jeffrey

Volltext

Trastuzumab‐based neoadjuvant therapy in patients with HER2‐positive breast cancer von Chang, Helena R.

Volltext

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy von Prati, Raquel, Minami, Christina A., Gornbein, Jeff A., Debruhl, Nanette, Chung, Debbie, Chang, Helena R.

Volltext

Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? von Burge, Chandra N., Chang, Helena R., Apple, Sophia K.

Volltext

The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR von Chin, Randall M., Fu, Xudong, Pai, Melody Y., Vergnes, Laurent, Hwang, Heejun, Deng, Gang, Diep, Simon, Lomenick, Brett, Meli, Vijaykumar S., Monsalve, Gabriela C., Hu, Eileen, Whelan, Stephen A., Wang, Jennifer X., Jung, Gwanghyun, Solis, Gregory M., Fazlollahi, Farbod, Kaweeteerawat, Chitrada, Quach, Austin, Nili, Mahta, Krall, Abby S., Godwin, Hilary A., Chang, Helena R., Faull, Kym F., Guo, Feng, Jiang, Meisheng, Trauger, Sunia A., Saghatelian, Alan, Braas, Daniel, Christofk, Heather R., Clarke, Catherine F., Teitell, Michael A., Petrascheck, Michael, Reue, Karen, Jung, Michael E., Frand, Alison R., Huang, Jing

Volltext

Integrated multiomic predictors for ovarian cancer survival von Fu, Alan, Chang, Helena R, Zhang, Zuo-Feng

Volltext

HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma von Sun, Na, Zhang, Ceng, Lee, Yi-Te, Tran, Benjamin V, Wang, Jing, Kim, Hyoyong, Lee, Junseok, Zhang, Ryan Y, Wang, Jasmine J, Hu, Junhui, Zhang, Zhicheng, Alsudaney, Manaf S, Hou, Kuan-Chu, Tang, Hubert, Zhang, Tiffany X, Liang, Icy Y, Zhou, Ziang, Chen, Mengxiang, Yeh, Angela Hsiao-Jiun, Li, Wenyuan, Zhou, Xianghong Jasmine, Chang, Helena R, Han, Steven-Huy B, Sadeghi, Saeed, Finn, Richard S, Saab, Sammy, Busuttil, Ronald W, Noureddin, Mazen, Ayoub, Walid S, Kuo, Alexander, Sundaram, Vinay, Al-Ghaieb, Buraq, Palomique, Juvelyn, Kosari, Kambiz, Kim, Irene K, Todo, Tsuyoshi, Nissen, Nicholas N, Tomasi, Maria Lauda, You, Sungyong, Posadas, Edwin M, Wu, James X, Wadehra, Madhuri, Sim, Myung-Shin, Li, Yunfeng, Wang, Hanlin L, French, Samuel W, Lu, Shelly C, Wu, Lily, Pei, Renjun, Liang, Li, Yang, Ju Dong, Agopian, Vatche G, Tseng, Hsian-Rong, Zhu, Yazhen

Volltext

Management Options in Triple-Negative Breast Cancer von Minami, Christina A., Chung, Debra U., Chang, Helena R.

Volltext

CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer von Deng, Xinyu, Apple, Sophia, Zhao, Hong, Song, Jeongyoon, Lee, Minna, Luo, William, Wu, Xiancheng, Chung, Debra, Pietras, Richard J, Chang, Helena R

Volltext

EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer von Chan, Ann M, Aguirre, Brian, Liu, Lucia, Mah, Vei, Balko, Justin M, Tsui, Jessica, Wadehra, Navin P, Moatamed, Neda A, Khoshchehreh, Mahdi, Dillard, Christen M, Kiyohara, Meagan, Elshimali, Yahya, Chang, Helena R, Marquez-Garban, Diana, Hamilton, Nalo, Pietras, Richard J, Gordon, Lynn K, Wadehra, Madhuri

Volltext

Mass Spectrometry (LC–MS/MS) Identified Proteomic Biosignatures of Breast Cancer in Proximal Fluid von Whelan, Stephen A, He, Jianbo, Lu, Ming, Souda, Puneet, Saxton, Romaine E, Faull, Kym F, Whitelegge, Julian P, Chang, Helena R

Volltext

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast von Ping, Zheng, Siegal, Gene P, Harada, Shuko, Eltoum, Isam-Eldin, Youssef, Mariam, Shen, Tiansheng, He, Jianbo, Huang, Yingjie, Chen, Dongquan, Li, Yiping, Bland, Kirby I, Chang, Helena R, Shen, Dejun

Volltext

Mass Spectrometry (LC-MS/MS) Site-Mapping of N-Glycosylated Membrane Proteins for Breast Cancer Biomarkers von Whelan, Stephen A., Lu, Ming, He, Jianbo, Yan, Weihong, Saxton, Romaine E., Faull, Kym F., Whitelegge, Julian P., Chang, Helena R.

Volltext

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer von Nguyen, Vina P, Campbell, Katie M, Nowicki, Theodore S, Elumalai, Nila, Medina, Egmidio, Baselga-Carretero, Ignacio, DiNome, Maggie L, Chang, Helena R, Oseguera, Denise K, Ribas, Antoni, Glaspy, John A

Volltext

Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis von Shen, Dejun, Nooraie, Farzad, Elshimali, Yahya, Lonsberry, Victor, He, Jianbo, Bose, Shikha, Chia, David, Seligson, David, Chang, Helena R., Goodglick, Lee

Volltext

Combined Phosphoproteomics and Bioinformatics Strategy in Deciphering Drug Resistant Related Pathways in Triple Negative Breast Cancer von Deng, Xinyu, Kohanfars, Morris, Hsu, Huan Ming, Souda, Puneet, Capri, Joe, Whitelegge, Julian P., Chang, Helena R.

Volltext

The Effect of Young Age in Hormone Receptor Positive Breast Cancer von Chang, Helena R., Gornbein, Jeffrey, Cao, Minh-an, Chung, Debra U., Varzi, Leo A., Lee, Minna K., Apple, Sophia K.

Volltext

Heterotopic breast tissue versus occult metastatic carcinoma in lymph node, a diagnostic dilemma von Ohsie, Steven J., MD, Moatamed, Neda A., MD, Chang, Helena R., MD, PhD, Apple, Sophia K., MD

Volltext

Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass Spectrometer von Lu, Ming, Whelan, Stephen A, He, Jianbo, Saxton, Romaine E, Faull, Kym F, Whitelegge, Julian P, Chang, Helena R

Volltext